135 related articles for article (PubMed ID: 25379136)
1. Sex hormone pathway gene polymorphisms are associated with risk of advanced hepatitis C-related liver disease in males.
White DL; Liu Y; Garcia J; El-Serag HB; Jiao L; Tsavachidis S; Franco LM; Lee JS; Tavakoli-Tabasi S; Moore D; Goldman R; Kuzniarek J; Ramsey DJ; Kanwal F; Marcelli M
Int J Mol Epidemiol Genet; 2014; 5(3):164-76. PubMed ID: 25379136
[TBL] [Abstract][Full Text] [Related]
2. WNT signaling pathway gene polymorphisms and risk of hepatic fibrosis and inflammation in HCV-infected patients.
Liu Y; El-Serag HB; Jiao L; Lee J; Moore D; Franco LM; Tavakoli-Tabasi S; Tsavachidis S; Kuzniarek J; Ramsey DJ; White DL
PLoS One; 2013; 8(12):e84407. PubMed ID: 24386373
[TBL] [Abstract][Full Text] [Related]
3. Finasteride and methadone use and risk of advanced hepatitis C related liver disease.
White DL; Hashmi A; Ramsey DJ; Kuzniarek J; Tavakoli-Tabasi S; El-Serag HB
Dig Dis Sci; 2012 Nov; 57(11):3004-10. PubMed ID: 22669204
[TBL] [Abstract][Full Text] [Related]
4. IL15 polymorphism is associated with advanced fibrosis, inflammation-related biomarkers and virological response in human immunodeficiency virus/hepatitis C virus coinfection.
Jiménez-Sousa MA; Berenguer J; Rallón N; Pineda-Tenor D; Aldamiz-Echevarria T; Soriano V; García-Álvarez M; Vazquez-Morón S; Restrepo C; Carrero A; Benito JM; Resino S
Liver Int; 2016 Sep; 36(9):1258-66. PubMed ID: 26836972
[TBL] [Abstract][Full Text] [Related]
5. Influence of cytokine and cytokine receptor gene polymorphisms on the degree of liver damage in patients with chronic hepatitis C.
Moreira ST; Silva GF; de Moraes CF; Grotto RM; de Moura Campos Pardini MI; Bicalho Mda G; Moliterno RA
Meta Gene; 2016 Sep; 9():90-6. PubMed ID: 27200267
[TBL] [Abstract][Full Text] [Related]
6. CXCL9-11 polymorphisms are associated with liver fibrosis in patients with chronic hepatitis C: a cross-sectional study.
Jiménez-Sousa MÁ; Gómez-Moreno AZ; Pineda-Tenor D; Medrano LM; Sánchez-Ruano JJ; Fernández-Rodríguez A; Artaza-Varasa T; Saura-Montalban J; Vázquez-Morón S; Ryan P; Resino S
Clin Transl Med; 2017 Dec; 6(1):26. PubMed ID: 28755163
[TBL] [Abstract][Full Text] [Related]
7. Genome-Wide Association Study Identifies TLL1 Variant Associated With Development of Hepatocellular Carcinoma After Eradication of Hepatitis C Virus Infection.
Matsuura K; Sawai H; Ikeo K; Ogawa S; Iio E; Isogawa M; Shimada N; Komori A; Toyoda H; Kumada T; Namisaki T; Yoshiji H; Sakamoto N; Nakagawa M; Asahina Y; Kurosaki M; Izumi N; Enomoto N; Kusakabe A; Kajiwara E; Itoh Y; Ide T; Tamori A; Matsubara M; Kawada N; Shirabe K; Tomita E; Honda M; Kaneko S; Nishina S; Suetsugu A; Hiasa Y; Watanabe H; Genda T; Sakaida I; Nishiguchi S; Takaguchi K; Tanaka E; Sugihara J; Shimada M; Kondo Y; Kawai Y; Kojima K; Nagasaki M; Tokunaga K; Tanaka Y;
Gastroenterology; 2017 May; 152(6):1383-1394. PubMed ID: 28163062
[TBL] [Abstract][Full Text] [Related]
8. Association of androgen metabolism gene polymorphisms with prostate cancer risk and androgen concentrations: Results from the Prostate Cancer Prevention Trial.
Price DK; Chau CH; Till C; Goodman PJ; Leach RJ; Johnson-Pais TL; Hsing AW; Hoque A; Parnes HL; Schenk JM; Tangen CM; Thompson IM; Reichardt JK; Figg WD
Cancer; 2016 Aug; 122(15):2332-40. PubMed ID: 27164191
[TBL] [Abstract][Full Text] [Related]
9. Genetic variants upstream of TNFAIP3 in the 6q23 region are associated with liver disease severity in HIV/HCV-coinfected patients: A cross-sectional study.
Jiménez-Sousa MA; Berenguer J; Fernández-Rodríguez A; Medrano LM; Aldámiz-Echevarria T; Pérez-Latorre L; Díez C; Martín-Vicente M; Gutiérrez-Rivas M; Martínez I; Resino S
Infect Genet Evol; 2019 Jan; 67():112-120. PubMed ID: 30336268
[TBL] [Abstract][Full Text] [Related]
10. Coffee and Caffeine Are Associated With Decreased Risk of Advanced Hepatic Fibrosis Among Patients With Hepatitis C.
Khalaf N; White D; Kanwal F; Ramsey D; Mittal S; Tavakoli-Tabasi S; Kuzniarek J; El-Serag HB
Clin Gastroenterol Hepatol; 2015 Aug; 13(8):1521-31.e3. PubMed ID: 25777972
[TBL] [Abstract][Full Text] [Related]
11. Toll-like receptor 8 (TLR8) polymorphisms are associated with non-progression of chronic hepatitis C in HIV/HCV coinfected patients.
Fernández-Rodríguez A; Berenguer J; Jiménez-Sousa MA; García-Álvarez M; Aldámiz-Echevarría T; Pineda-Tenor D; Diez C; de la Barrera J; Bellon JM; Briz V; Resino S
Infect Genet Evol; 2015 Dec; 36():339-344. PubMed ID: 26455634
[TBL] [Abstract][Full Text] [Related]
12. Liver fibrosis progression at autopsy in injecting drug users infected by hepatitis C: a longitudinal long-term cohort study.
Kielland KB; Delaveris GJ; Rogde S; Eide TJ; Amundsen EJ; Dalgard O
J Hepatol; 2014 Feb; 60(2):260-6. PubMed ID: 24096048
[TBL] [Abstract][Full Text] [Related]
13. Genetic associations of vitamin D receptor polymorphisms with advanced liver fibrosis and response to pegylated interferon-based therapy in chronic hepatitis C.
Thanapirom K; Suksawatamnuay S; Sukeepaisarnjaroen W; Tangkijvanich P; Thaimai P; Wasitthankasem R; Poovorawan Y; Komolmit P
PeerJ; 2019; 7():e7666. PubMed ID: 31565578
[TBL] [Abstract][Full Text] [Related]
14. Polymorphism Thr160Thr in SRD5A1, involved in the progesterone metabolism, modifies postmenopausal breast cancer risk associated with menopausal hormone therapy.
Hein R; Abbas S; Seibold P; Salazar R; Flesch-Janys D; Chang-Claude J
Breast Cancer Res Treat; 2012 Jan; 131(2):653-61. PubMed ID: 21947678
[TBL] [Abstract][Full Text] [Related]
15. Association of diabetes and PNPLA3 genetic variants with disease severity of patients with chronic hepatitis C virus infection.
Huang CF; Dai CY; Yeh ML; Huang CI; Tai CM; Hsieh MH; Liang PC; Lin YH; Hsieh MY; Yang HL; Huang JF; Lin ZY; Chen SC; Yu ML; Chuang WL
J Hepatol; 2015 Mar; 62(3):512-8. PubMed ID: 25457210
[TBL] [Abstract][Full Text] [Related]
16. The Synergistic Effect of TNFα -308 G/A and TGFβ1 -509 C/T Polymorphisms on Hepatic Fibrosis Progression in Hepatitis C Virus Genotype 4 Patients.
Bader El Din NG; Farouk S; El-Shenawy R; Elhady MM; Ibrahim MK; Dawood RM; Salem AM; El Awady MK
Viral Immunol; 2017 Mar; 30(2):127-135. PubMed ID: 28151059
[TBL] [Abstract][Full Text] [Related]
17. Predictors of liver fibrosis in HIV-infected patients with chronic hepatitis C virus (HCV) infection: assessment using transient elastometry and the role of HCV genotype 3.
Barreiro P; Martín-Carbonero L; Núñez M; Rivas P; Morente A; Simarro N; Labarga P; González-Lahoz J; Soriano V
Clin Infect Dis; 2006 Apr; 42(7):1032-9. PubMed ID: 16511772
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-28B rs12979860 C allele: Protective against advanced fibrosis in chronic hepatitis C genotype 1 infection.
Kitson MT; George J; Dore GJ; Leung R; Button P; McCaughan GW; Grawford DH; Siebert W; Weltman MD; Cheng WS; Roberts SK
J Gastroenterol Hepatol; 2014; 29(7):1458-62. PubMed ID: 25587616
[TBL] [Abstract][Full Text] [Related]
19. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups.
Poynard T; Bedossa P; Opolon P
Lancet; 1997 Mar; 349(9055):825-32. PubMed ID: 9121257
[TBL] [Abstract][Full Text] [Related]
20. Peripheral blood and hepatic Toll-like receptor 7 expression and interferon lambda 1 levels in chronic hepatitis C: Relation to virus replication and liver injury.
El Aggan H; Farahat N; El Deeb N; Zeid A; El-Shendidi A
Microb Pathog; 2019 Jun; 131():65-74. PubMed ID: 30926417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
